(Q39470386)

12 September 2017

1 reference

title

Controlled beta-receptor blockade with esmolol and flestolol (English)

1 reference

12 September 2017

Murthy VS

1

1 reference

12 September 2017

Frishman WH

series ordinal

2

1 reference

12 September 2017

language of work or name

English

0 references

publication date

1 January 1988

1 reference

12 September 2017

1 reference

12 September 2017

volume

8

1 reference

12 September 2017

issue

3

1 reference

12 September 2017

page(s)

168-182

1 reference

Adrenoceptor blocking drugs: clinical pharmacology and therapeutic use.

12 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1002%2FJ.1875-9114.1988.TB04071.X

beta-Adrenoceptor antagonists: new drugs and new indications

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1875-9114.1988.TB04071.X

Use of beta adrenoceptor blockade during and after acute myocardial infarction

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1875-9114.1988.TB04071.X

Beta-adrenergic blocking drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1875-9114.1988.TB04071.X

Immediate effects of intravenous propranolol on various cardiac arrhythmias.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1875-9114.1988.TB04071.X

Ultra-short acting beta-blockers: A proposal for the treatment of the critically ill patient

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1875-9114.1988.TB04071.X

The clinical importance of cardioselectivity and lipophilicity in beta blockers.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1875-9114.1988.TB04071.X

Ultra-short-acting .beta.-adrenergic receptor blocking agents. 1. (Aryloxy)propanolamines containing esters in the nitrogen substituent

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1875-9114.1988.TB04071.X

Ultra-short-acting beta-adrenergic receptor blocking agents. 2. (Aryloxy)propanolamines containing esters on the aryl function

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1875-9114.1988.TB04071.X

Cardiovascular pharmacology of ASL-8052, an ultra-short acting beta blocker.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1875-9114.1988.TB04071.X

Esmolol and the adrenergic response to perioperative stimuli

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1875-9114.1988.TB04071.X

Effects of intravenous infusion of esmolol and propranolol on biventricular performance at rest and during exercise as assessed by quantitative radionuclide angiography

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1875-9114.1988.TB04071.X

Speed of onset of pharmacodynamic activity of propranolol, practolol, oxprenolol and metoprolol after intravenous infection in man

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1875-9114.1988.TB04071.X

Electrophysiological properties of intravenous metoprolol in man

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1875-9114.1988.TB04071.X

Pharmacology and pharmacokinetics of esmolol.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1875-9114.1988.TB04071.X

First ultra-short-acting beta-adrenergic blocking agent: Its effect on size and segmental wall dynamics of reperfused myocardial infarcts in dogs

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1875-9114.1988.TB04071.X

Effects of propranolol on myocardial infarct size with and without coronary artery reperfusion in the dog

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1875-9114.1988.TB04071.X

Limitation of myocardial infarct size by atenolol, nadolol and propranolol in dogs

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1875-9114.1988.TB04071.X

[(Arylcarbonyl)oxy]propanolamines. 1. Novel beta-blockers with ultrashort duration of action

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1875-9114.1988.TB04071.X

Pharmacokinetics and pharmacodynamics of flestolol, a new short-acting, beta-adrenergic receptor antagonist

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1875-9114.1988.TB04071.X

Tolerance and beta-adrenergic blocking activity of flestolol, a short-acting beta blocker

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1875-9114.1988.TB04071.X

Beta-adrenergic receptor blocking drugs in cardiac arrhythmias

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1875-9114.1988.TB04071.X

Conversion of atrial fibrillation and flutter by propranolol

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1875-9114.1988.TB04071.X

Appraisal of the effects of catecholamines on cardiac electrical activity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1875-9114.1988.TB04071.X

Pharmacologic therapy of ventricular arrhythmias

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1875-9114.1988.TB04071.X

Effective treatment of supraventricular arrhythmias with acebutolol

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1875-9114.1988.TB04071.X

Antiarrhythmic effects of intravenous timolol in supraventricular arrhythmias

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1875-9114.1988.TB04071.X

Role of beta-adrenergic blockade in the therapy of patients with myocardial infarction

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1875-9114.1988.TB04071.X

Effect of metoprolol on indirect signs of the size and severity of acute myocardial infarction

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1875-9114.1988.TB04071.X

Reduction of Infarct Size with the Early Use of Timolol in Acute Myocardial Infarction

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1875-9114.1988.TB04071.X

Limitation of myocardial infarct size in patients less than 66 years treated with alprenolol

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1875-9114.1988.TB04071.X

Protective effect of propranolol in threatened myocardial infarction

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1875-9114.1988.TB04071.X

Use of an ultra short-acting beta-blocker in patients with acute myocardial ischemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1875-9114.1988.TB04071.X

Anaesthesia and the hypertensive patient

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1875-9114.1988.TB04071.X

Continuous monitoring of left ventricular performance with the computerized nuclear probe during laryngoscopy and intubation before coronary artery bypass surgery.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1875-9114.1988.TB04071.X

Preoperative Propranolol Therapy and Aortocoronary Bypass Operation

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1875-9114.1988.TB04071.X

Effects of intubation on coronary blood flow and myocardial oxygenation

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1875-9114.1988.TB04071.X

Esmolol for control of increases in heart rate and blood pressure during tracheal intubation after thiopentone and succinylcholine.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1875-9114.1988.TB04071.X

Cardiovascular and neuromuscular effects of esmolol during induction of anesthesia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1875-9114.1988.TB04071.X

Systemic arterial hypertension associated with cardiac surgery.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1875-9114.1988.TB04071.X

Use of esmolol in hypertension after cardiac surgery.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1875-9114.1988.TB04071.X

10.1002/J.1875-9114.1988.TB04071.X

21 January 2018

Identifiers

DOI

1 reference

12 September 2017

1 reference